Evidence map›Paper›PMID 24949855›Full record

ArticlePloS one2014

A systems biology approach to the analysis of subset-specific responses to lipopolysaccharide in dendritic cells.

David G Hancock, Elena Shklovskaya, Thomas V Guy, Reza Falsafi, Chris D Fjell, William Ritchie, Robert E W Hancock, Barbara Fazekas de St Groth

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

David G HancockCentenary Institute of Cancer Medicine and Cell Biology, New South Wales, Australia; The Discipline of Dermatology, University of Sydney, New South Wales, Australia.
Elena ShklovskayaCentenary Institute of Cancer Medicine and Cell Biology, New South Wales, Australia; The Discipline of Dermatology, University of Sydney, New South Wales, Australia.
Thomas V GuyCentenary Institute of Cancer Medicine and Cell Biology, New South Wales, Australia; The Discipline of Dermatology, University of Sydney, New South Wales, Australia.
Reza FalsafiCentre for Microbial Diseases & Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.
Chris D FjellCentre for Microbial Diseases & Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada; James Hogg Research Centre, University of British Columbia, St. Paul's Hospital, Vancouver, British Columbia, Canada.
William RitchieCentenary Institute of Cancer Medicine and Cell Biology, New South Wales, Australia.
Robert E W HancockCentre for Microbial Diseases & Immunity Research, University of British Columbia, Vancouver, British Columbia, Canada.
Barbara Fazekas de St GrothCentenary Institute of Cancer Medicine and Cell Biology, New South Wales, Australia; The Discipline of Dermatology, University of Sydney, New South Wales, Australia.
Centenary Institute · AUUniversity of British Columbia · CAThe University of Sydney · AU

Funding

Canadian Institutes of Health Research MOP-74493
6 · The paper itself

Abstract

Dendritic cells (DCs) are critical for regulating CD4 and CD8 T cell immunity, controlling Th1, Th2, and Th17 commitment, generating inducible Tregs, and mediating tolerance. It is believed that distinct DC subsets have evolved to control these different immune outcomes. However, how DC subsets mount different responses to inflammatory and/or tolerogenic signals in order to accomplish their divergent functions remains unclear. Lipopolysaccharide (LPS) provides an excellent model for investigating responses in closely related splenic DC subsets, as all subsets express the LPS receptor TLR4 and respond to LPS in vitro. However, previous studies of the LPS-induced DC transcriptome have been performed only on mixed DC populations. Moreover, comparisons of the in vivo response of two closely related DC subsets to LPS stimulation have not been reported in the literature to date. We compared the transcriptomes of murine splenic CD8 and CD11b DC subsets after in vivo LPS stimulation, using RNA-Seq and systems biology approaches. We identified subset-specific gene signatures, which included multiple functional immune mediators unique to each subset. To explain the observed subset-specific differences, we used a network analysis approach. While both DC subsets used a conserved set of transcription factors and major signalling pathways, the subsets showed differential regulation of sets of genes that 'fine-tune' the network Hubs expressed in common. We propose a model in which signalling through common pathway components is 'fine-tuned' by transcriptional control of subset-specific modulators, thus allowing for distinct functional outcomes in closely related DC subsets. We extend this analysis to comparable datasets from the literature and confirm that our model can account for cell subset-specific responses to LPS stimulation in multiple subpopulations in mouse and man.

Indexed as

Systems BiologyAnimalsCD11b AntigenCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDendritic CellsGene Expression RegulationImmune ToleranceImmunityImmunophenotypingLipopolysaccharidesLymphocyte ActivationMiceTh1 CellsT-Lymphocytes, Helper-InducerToll-Like Receptor 4CD11b AntigenLipopolysaccharidesToll-Like Receptor 4

Identifiers

PMID24949855
PMCPMC4065045
OpenAlexW2031219310

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.